Changing customer needs, growing and ageing populations, increasingly empowered patients and mounting funding pressures will all dramatically impact on the healthcare of the future.  Our business strategy has been formulated to ensure we remain an industry leader in the face of these trends.

The core of our strategy for long-term success can be summed up in a single word: ‘innovation’. Our mission is to bring tangible improvements to the health and quality and length of life of patients who use our products.  So that we can continue to fulfil this mission:

• We will focus on developing medically differentiated products in therapy areas of high medical need.
• We will use the evolving science of personalised healthcare as a source for developing medically differentiated products.
• We will invest in emerging technologies that we identify as critical to securing our R&D pipeline.
• We will use external innovation partnerships (commercial and academic) to strengthen and/or complement our areas of focus.
• We will continue to build an innovation network by being the partner of choice.

With a business strategy focused on developing and marketing medically differentiated products and services that offer high value to patients and healthcare systems, Roche is well positioned to face a changing healthcare environment.